Previous 10 | Next 10 |
Gainers: LAKE +13.5% . ASPU +10.2% . CVIA +4.4% . AUPH +2.6%. BNFT +2.5% . More news on: Lakeland Industries, Inc., Aspen Group, Inc., Covia Holdings Corporation, Stocks on the move, , News on ETFs Read more ...
TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today provided a business update. Positive CGuard ™ EPS ...
TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today announced that James Barry, PhD, Chief Executive Officer and Craig...
TEL AVIV, Israel, Aug. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that it has received a letter from the N...
InspireMD, Inc. (NSPR) Q2 2019 Results Conference Call August 06, 2019 08:00 AM ET Company Participants Jeremy Feffer - IR Jim Barry - CEO Craig Shore - CFO Conference Call Participants Vernon Bernardino - H.C. Wainwright Presentation Operator Greetings, and welco...
U.S. Investigational Device Exemption (IDE) application submitted to FDA Company to host investor conference call today, August 6, at 8:00am ET TEL AVIV, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevent...
TEL AVIV, Israel, July 30, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and ...
Gainers: MGI +117.9% . PHAS +14.0% . NSPR +7.4% . EIGR +4.9% . ARQL +2.7% . More news on: MoneyGram International, Inc., PhaseBio Pharmaceuticals, Inc., InspireMD, Inc., Stocks on the move, , News on ETFs Read more ...
InspireMD, Inc. Corp. (NSPR) Q1 2019 Results Earnings Conference Call May 14, 2019, 08:00 AM ET Company Participants Jeremy Feffer - IR, LifeSci Advisors, LLC Jim Barry - CEO Craig Shore - CFO Conference Call Participants Presentation Operator Greetings and welcome ...
Gainers: Big 5 Sporting Goods (NASDAQ: BGFV ) +26% . Novavax (NASDAQ: NVAX ) +25% . Asta Funding (NASDAQ: ASFI ) +20% . MeiraGTx Holdings (NASDAQ: MGTX ) +19% . Luokung Technology (NASDAQ: LKCO ) +18% . Key Energy Services (NYSE: KEG ) +17% . Verastem (NASDAQ: VSTM ) +17% . Su...
News, Short Squeeze, Breakout and More Instantly...
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel, and MIAMI, July 30, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prev...
Series H warrants exercisable following release of positive outcomes results related to one-year follow-up from the Company’s C-GUARDIANS pivotal trial. Participating warrant holders include Marshall Wace, OrbiMed, Rosalind, Nantahala, Soleus, Velan, and certain InspireMD Board m...
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection device pivotal trial Study results to support a Premarket Approval (PMA) application to FDA in H2 2024 U.S. commercial launch of...